Albert Bourla and COVID-19 Vaccine

Selected healthcare news for the person - Albert Bourla, and the healthcare topic - COVID-19 Vaccine. We have 396 shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
8/16/2021 Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine | Business Wire Business Wire ... U.S. Food and Drug Administration (FDA) to support the evaluation of a third, or booster, dose of the companies‚Ao COVID-19 vaccine (BNT162b2) for future licensure. These data also will be submitted to the ... must remain vigilant against this highly contagious virus,‚Au said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. ‚AuThe data we‚Aove seen to date suggest a third dose of our vaccine elicits antibody levels ...
8/16/2021 MAKING A KILLING: Pfizer continues push for COVID-19 vaccine boosters despite lack of late-stage clinical trial results Natural News ) Pfizer CEO Albert Bourla recently expressed confidence that a booster would increase the immunity levels of people who already received two doses of the company‚Aos coronavirus (COVID-19) vaccine. ‚AuWe are very ... are required before regulatory approval. Drug regulators not sold on COVID-19 vaccine boosters Pfizer and partner BioNTech said last month that they plan to ask U.S. and European regulators to authorize a booster dose ...
8/16/2021 Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine ... the U.S. Food and Drug Administration (FDA) to support the evaluation of a third, or booster, dose of the companies' COVID-19 vaccine (BNT162b2) for future licensure. These data also will be submitted to the ... we must remain vigilant against this highly contagious virus," said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. "The data we've seen to date suggest a third dose of our vaccine elicits antibody levels that ...
8/16/2021 COVID-19 vaccine | Pfizer urges third dose clearance COVID-19 vaccine Pfizer urges third dose clearance (Washington) The Pfizer / BioNTech alliance on Monday asked U.S. health officials for future approval of a third dose for all of their COVID-19 vaccines, with encouraging ... in excess of the two originally planned doses,‚Au said Albert Bourla, CEO of Pfizer, in a press release. The two companies have therefore ‚Ausubmitted phase 1 data‚Au [d‚Aoessais cliniques, NDLR] to the ...
8/13/2021 Bennett asks Pfizer CEO to speed up vaccine approval for kids under 12 | The Times of Israel Prime Minister Naftali Bennett spoke on Thursday with Pfizer CEO Albert Bourla and urged him to speed up regulatory approval of the pharmaceutical giant‚Aos COVID-19 vaccine for those under the age of 12.Bourla told Bennett he views the issue with great importance and will work to the best of his ability to speed up the process, according to the Prime Minister‚Aos Office.The pair also discussed ...
8/5/2021 Is BioNTech Contradicting Pfizer About the Need for Booster Doses? ... COVID-19 vaccine makers seem to agree, either. In this Motley Fool Live video recorded on July 28, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not BioNTech ( NASDAQ:BNTX ) is contradicting its big partner, Pfizer ( NYSE:PFE ), about the need for booster doses. Keith Speights: Let's move to another COVID story. I think most of our viewers are aware that Pfizer CEO Albert Bourla hasn't been ...
8/5/2021 Is BioNTech Contradicting Pfizer About the Need for Booster Doses? - NewsBreak Key Points Pfizer CEO Albert Bourla has maintained for a while now that third booster doses of the Pfizer-BioNTech COVID-19 vaccine will likely be needed. BioNTech CEO Ugur Sahin, however, recently stated that he's not calling for a third booster shot yet. The two executives really aren't on completely different pages, though. Will a third booster dose be needed or not? Not all healthcare experts agree on the ...
8/4/2021 With Delta variant surging, FDA hustles to grant Pfizer's COVID-19 vaccine a full approval: reports FiercePharma The FDA has stepped up its efforts to grant full approval for Pfizer and BioNTech‚Aos COVID-19 vaccine, setting an unofficial deadline of Labor Day, The New York Times reports.With the Delta variant ... mandate vaccinations.During an earnings call last week, Pfizer CEO Albert Bourla said a full approval would help convince holdouts to get vaccinated.‚AuSome people will change their reluctance to willingness,‚Au Bourla said. ‚AuAnd ...
8/2/2021 Pfizer, Moderna hike COVID-19 vaccine prices in new European supply deals: report FiercePharma ... the companies are charging more for their doses.Pfizer and Moderna have both raised the price of their mRNA-based COVID-19 vaccines in Europe, The Financial Times first reported . Pfizer‚Aos shot will cost ... company spokesperson said over email, citing comments Pfizer‚Aos CEO Albert Bourla made in May at the European Commission‚Aos Global Health Pre-Summit.Under the system, wealthier countries pay ‚Auabout the cost of a ...
8/2/2021 Pfizer and Moderna Hike the Price of COVID Vaccines ... to become a lot more expensive for some countries.European nations will now pay 25 percent more for Pfizer‚Aos COVID-19 vaccines and 10 percent more for Moderna‚Aos, the Financial Times reports , bringing ... than selling it at cost like AstraZeneca.Though Pfizer CEO Albert Bourla didn‚Aot directly connect the higher costs in Europe to lower costs elsewhere in his second-quarter earnings call statement last week, he ...
8/2/2021 Pfizer, Moderna Hike COVID-19 Vaccine Prices by as Much as 26% In Europe‚ÄîHere's Why Pfizer and Moderna have the best COVID-19 vaccines on the market. But they are about to cost a lot more. The two vaccine makers have raised the prices of their mRNA-based coronavirus vaccines ... a company spokesperson told Fierce Pharma , citing comments Pfizer CEO Albert Bourla made in May at the European Commission‚Aos Global Health Pre-Summit. According to Pfizer‚Aos tiered pricing structure, wealthy countries pay ‚Auabout ...
7/31/2021 Medical experts hoping for youth COVID-19 vaccination availability by September As the delta variant continues to significantly affect the younger population, medical experts are hoping to have COVID-19 vaccinations available for youth this fall. Pfizer-BioNTech has requested authorization from the U.S. Food and Drug Administration to expand the emergency use of their COVID-19 vaccine for individuals ages 12 to 15. Albert Bourla, Pfizer chairman and CEO, said during a quarterly earnings conference call in May that they ...
7/28/2021 PFIZER REPORTS SECOND-QUARTER 2021 RESULTS | Business Wire Business Wire ... COVID-19 vaccine, as well as its business excluding BNT162b2 (1) .Additionally, Pfizer published this morning on its website the second-quarter 2021 earnings presentation and accompanying prepared remarks from management as well as the quarterly update to its R&D pipeline.EXECUTIVE COMMENTARYDr. Albert Bourla, Chairman and Chief Executive Officer, stated: ‚AuThe second quarter was remarkable in a number of ways. Most visibly, the speed and efficiency of ...
7/28/2021 PFIZER REPORTS SECOND-QUARTER 2021 RESULTS Business Wire ... COVID-19 vaccine, as well as its business excluding BNT162b2 (1). Additionally, Pfizer published this morning on its website the second-quarter 2021 earnings presentation and accompanying prepared remarks from management as well as the quarterly update to its R&D pipeline. EXECUTIVE COMMENTARY Dr. Albert Bourla, Chairman and Chief Executive Officer, stated: ‚AuThe second quarter was remarkable in a number of ways. Most visibly, the speed and efficiency of ...
7/28/2021 Pfizer now expects COVID vaccine sales to reach $33.5B this year, a whopping $7.5B bump from its estimate 3 months ago FiercePharma ... days during the Summer Olympic Games. Now it‚Aos Pfizer‚Aos turn.Three months after estimating 2021 revenues for its COVID-19 vaccine Comirnaty would reach a whopping $26 billion, Pfizer has jacked up its ... was remarkable in a number of ways,‚Au Pfizer CEO Albert Bourla said in a release. ‚AuMost visibly, the speed and efficiency of our efforts with BioNTech to help vaccinate the world against COVID-19 ...
7/28/2021 Pfizer authorizes $1 billion for oral COVID-19 treatment, CEO says Yahoo News Pfizer ( PFE ) CEO Albert Bourla is betting big on repeating the success of its COVID-19 vaccine with an experimental oral treatment ‚Ai and he's putting the company's money where its mouth is.Bourla told Yahoo Finance Wednesday the company is committing $1 billion to develop the oral treatment ‚Ai a protease inhibitor ‚Ai which would give the world an easy-to-use, targeted treatment, hopefully by year's end.The ...
7/28/2021 Pfizer's CEO Says Covid Vaccine Effectiveness Drops to 84% After Six Months CNBC The effectiveness of Pfizer's Covid-19 vaccine steadily declines over time, dropping to about 84% for vaccinated people about four to six months after getting their second dose, according to CEO Albert Bourla. The comments, made on Wednesday on CNBC's " The Exchange ," are based on the findings of a new company-funded study that has yet to be peer reviewed. It comes as the drugmaker clashes with U.S. health officials ...
7/23/2021 In venue fit for head of state, Japan PM seeks Pfizer doses Star Telegram National Politics] In venue fit for head of state, Japan PM seeks Pfizer doses Japan's prime minister met with Pfizer's CEO in an unusually high-profile setting Friday to make sure the drugmaker would deliver the COVID-19 vaccine as promised by this fall as the nation faces supply concerns and a growing outbreak. Pfizer Inc. CEO Albert Bourla, who is in Tokyo to attend Friday's opening ceremony of the ...
7/23/2021 In Venue Fit for Head of State, Japan PM Seeks Pfizer Doses | Health News | US News U.S. News & World Report ... COVID-19 vaccine as promised by this fall as the nation faces supply concerns and a growing outbreak.Pfizer Inc. CEO Albert Bourla, who is in Tokyo to attend Friday's opening ceremony of the Olympics, was greeted by Prime Minister Yoshihide Suga at the Akasaka Palace state guest house, usually used to welcome heads of state. Suga‚Aos special hospitality for Pfizer's leader comes as Japan is seeing its vaccination ...
7/23/2021 In venue fit for head of state, Japan PM seeks Pfizer doses MSN ... COVID-19 vaccine as promised by this fall as the nation faces supply concerns and a growing outbreak.Pfizer Inc. CEO Albert Bourla, who is in Tokyo to attend Friday's opening ceremony of the Olympics, was greeted by Prime Minister Yoshihide Suga at the Akasaka Palace state guest house, usually used to welcome heads of state. Suga‚Aos special hospitality for Pfizer's leader comes as Japan is seeing its vaccination ...
7/23/2021 In venue fit for head of state, Japan PM seeks Pfizer doses | FOX 56 Lexington TOKYO (AP) ‚Ai Japan‚Aos prime minister met with Pfizer‚Aos CEO in an unusually high-profile setting Friday to make sure the drugmaker would deliver the COVID-19 vaccine as promised by this fall as the nation faces supply concerns and a growing outbreak.Pfizer Inc. CEO Albert Bourla, who is in Tokyo to attend Friday‚Aos opening ceremony of the Olympics, was greeted by Prime Minister Yoshihide Suga ...
7/23/2021 In venue fit for head of state, Japan PM seeks Pfizer doses TOKYO (AP) ‚Ai Japan‚Aos prime minister met with Pfizer‚Aos CEO in an unusually high-profile setting Friday to make sure the drugmaker would deliver the COVID-19 vaccine as promised by this fall as the nation faces supply concerns and a growing outbreak. Pfizer Inc. CEO Albert Bourla, who is in Tokyo to attend Friday‚Aos opening ceremony of the Olympics, was greeted by Prime Minister Yoshihide Suga ...
7/23/2021 In venue fit for head of state, Japan PM seeks Pfizer doses TOKYO (AP) ‚Ai Japan‚Aos prime minister met with Pfizer‚Aos CEO in an unusually high-profile setting Friday to make sure the drugmaker would deliver the COVID-19 vaccine as promised by this fall as the nation faces supply concerns and a growing outbreak. Pfizer Inc. CEO Albert Bourla, who is in Tokyo to attend Friday‚Aos opening ceremony of the Olympics, was greeted by Prime Minister Yoshihide Suga ...
7/23/2021 In venue fit for head of state, Japan PM seeks Pfizer doses TOKYO (AP) ‚Ai Japan's prime minister met with Pfizer's CEO in an unusually high-profile setting Friday to make sure the drugmaker would deliver the COVID-19 vaccine as promised by this fall as the nation faces supply concerns and a growing outbreak. Pfizer Inc. CEO Albert Bourla, who is in Tokyo to attend Friday's opening ceremony of the Olympics, was greeted by Prime Minister Yoshihide Suga at the Akasaka ...
7/23/2021 In venue fit for head of state, Japan PM seeks Pfizer doses Click here to subscribe today] or [Login] . By MARI YAMAGUCHI TOKYO (AP) ‚Ai Japan‚Aos prime minister met with Pfizer‚Aos CEO in an unusually high-profile setting Friday to make sure the drugmaker would deliver the COVID-19 vaccine as promised by this fall as the nation faces supply concerns and a growing outbreak. Pfizer Inc. CEO Albert Bourla, who is in Tokyo to attend Friday‚Aos opening ceremony ...